Key facts
- This page summarizes Halley E. Gilbert's Form 4 filing for CytomX Therapeutics, Inc. (CTMX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 17 Jun 2022, 16:06.
Halley E. Gilbert - 15 Jun 2022 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)
- Role
- Director
- Signature
- /s/ Lloyd Rowland, as Attorney-in-Fact for Halley E. Gilbert
- Issuer symbol
- CTMX
- Transactions as of
- 15 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 17 Jun 2022, 16:06:22 UTC
- Previous filing
- 03 Jun 2022
- Next filing
- 02 Jun 2023
- SEC
- View on sec.gov
Key filing fact
Halley E. Gilbert filed Form 4 for CytomX Therapeutics, Inc. (CTMX) on 17 Jun 2022.
Change
- Previous filing in this sequence was filed on 03 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
CTMX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 15 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $1.72
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. |